UAB "ORION PHARMA" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,557,627 |
| 180,281 |
| 130,690 |
| 111,435 |
| 12,898 |
| 7.41 |
| 7.15 |
| 328,625 |
| 239,126 |
| 0 |
| 585,928 |
| 0.21 |
| 0.73 |
| - |
| - |
| 7.41 |
| 115,450 |
| 2024 |
|---|
| 1,580,272 |
| 154,173 |
| 125,943 |
| 101,185 |
| 9,872 |
| 7.40 |
| 6.40 |
| 159,809 |
| 62,034 |
| 0 |
| 309,649 |
| 0.10 |
| 0.39 |
| - |
| - |
| 7.40 |
| 117,006 |
| 2025 |
|---|
| 1,485,680 |
| 162,725 |
| 116,834 |
| 82,936 |
| 9,084 |
| 7.40 |
| 5.58 |
| 98,864 |
| 185,597 |
| 0 |
| 373,775 |
| 0.06 |
| 1.88 |
| - |
| - |
| 7.40 |
| 109,972 |
| 2025 |
|---|
| 1,485,680 |
| 162,725 |
| 116,834 |
| 82,936 |
| 9,084 |
| 7.40 |
| 5.58 |
| 98,864 |
| 185,597 |
| 0 |
| 373,775 |
| 0.06 |
| 1.88 |
| - |
| - |
| 7.40 |
| 109,972 |
Turnover (€)
2025
Turnover (€)
1,485,680 €-6 % *
Sales per employee (€)
162,725 €6 % *
Profit before tax (€)
116,834 €-7 % *
Net Profit (€)
82,936 €-18 % *
Profit per employee (€)
9,084 €-8 % *
Total profitability (%)
7.40 %0.00 % *
Net profitability (%)
5.58 %-12.81 % *
Equity (€)
98,864 €-38 % *
Amounts Payable And Liabilities (€)
185,597 €199 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
373,775 €21 % *
Working capital requirement
0.06 -40.00 % *
Debt-to-equity ratio
1.88 382.05 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
7.40 %0.00 % *
EBIT (€)
109,972 €-6 % *
